Search





Search





Markets
/
Stocks
/
atai
/

ATAI Life Sciences NV

ATAI

Add to Watchlist

7.180USD

0.0000.00%

Close 07-31 16:00（ET）Quotes delayed by 15 min

2.66BMarket Cap

LossP/E TTM

ATAI Life Sciences NV

7.180

0.0000.00%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

ATAI Cash Flow Statement

You can access the annual and quarterly cash flow statements of ATAI Life Sciences NV to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2020Q4

FY2020Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-18.21%-21.09M

-95.43%-47.48M

-20.27%-23.26M

13.15%-14.09M

20.96%-17.84M

-10.63%-24.30M

-4.94%-19.34M

28.24%-16.23M

-6.93%-22.57M

28.01%-21.96M

34.28%-18.43M

-3.11%-22.61M

11.99%-21.11M

-48.74%-30.50M

0.23%-28.05M

---21.93M

---23.99M

-230.05%-20.51M

-416.25%-28.11M

---6.21M

---5.45M

Net income from continuing operations

-12.61%-29.80M

-1297.34%-544.84M

-132.21%-61.10M

51.64%-27.75M

3.33%-26.46M

-103.69%-38.99M

-160.66%-26.31M

-69.87%-57.37M

20.31%-27.38M

58.97%-19.14M

221.49%43.37M

9.96%-33.77M

8.53%-34.35M

49.99%-46.65M

-12.83%-35.70M

---37.51M

---37.56M

1.15%-93.27M

61.97%-31.64M

---94.36M

---83.19M

Operating gains losses

-22.69%167.00K

-67.74%369.00K

180.72%233.00K

176.83%227.00K

160.24%216.00K

1032.67%1.14M

12.16%83.00K

3.80%82.00K

27.69%83.00K

90.57%101.00K

105.56%74.00K

315.79%79.00K

8.33%65.00K

82.76%53.00K

--36.00K

--19.00K

--60.00K

107.14%29.00K

----

--14.00K

--5.00K

Deferred tax

----

--5.07M

----

Other non-cash items

-113.53%-889.00K

5344.31%500.06M

1190.69%35.77M

-74.19%8.16M

188.79%6.57M

-87.48%9.19M

103.92%2.77M

2477.74%31.62M

176.76%2.27M

1600.30%73.33M

-1333.42%-70.77M

48.45%-1.33M

197.97%822.00K

23.51%4.31M

40.47%-4.94M

---2.58M

---839.00K

-71.79%3.49M

-24491.18%-8.29M

--12.38M

--34.00K

Change in working capital

216.60%2.02M

-179.78%-11.29M

58.59%-1.25M

170.76%7.80M

65.52%-1.73M

-253.01%-4.04M

-988.86%-3.03M

246.57%2.88M

-236.99%-5.01M

165.19%2.64M

902.94%341.00K

-60.97%831.00K

351.89%3.66M

-1555.04%-4.04M

100.70%34.00K

--2.13M

---1.45M

-93.12%278.00K

-5757.83%-4.86M

--4.04M

---83.00K

-Change in prepaid expenses

410.17%183.00K

-339.76%-1.22M

123.31%628.00K

23.96%1.34M

-521.43%-59.00K

-73.91%508.00K

-148.98%-2.69M

-63.04%1.08M

-99.71%14.00K

660.55%1.95M

60.18%-1.08M

31.28%2.92M

478.04%4.87M

709.52%256.00K

65.97%-2.72M

--2.23M

---1.29M

26.32%-42.00K

-1276.38%-7.98M

---57.00K

---580.00K

-Change in other current assets

----

---5.97M

----

-Change in other current liabilities

---19.00K

--766.00K

----

--0.00

---168.00K

--60.00K

----

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-18.21%-21.09M

-95.43%-47.48M

-20.27%-23.26M

13.15%-14.09M

20.96%-17.84M

-10.63%-24.30M

-4.94%-19.34M

28.24%-16.23M

-6.93%-22.57M

28.01%-21.96M

34.28%-18.43M

-3.11%-22.61M

11.99%-21.11M

-48.74%-30.50M

0.23%-28.05M

---21.93M

---23.99M

-230.05%-20.51M

-416.25%-28.11M

---6.21M

---5.45M

Investing cash flow

Net cash from continuing investing activities

-100.00%0.00

23.60%110.00K

536200.00%5.36M

--127.00K

120260.00%6.02M

423.53%89.00K

-50.00%1.00K

-100.00%0.00

-98.87%5.00K

-92.38%17.00K

-99.62%2.00K

-40.74%128.00K

691.07%443.00K

-37.54%223.00K

66.35%529.00K

--216.00K

--56.00K

614.00%357.00K

31700.00%318.00K

--50.00K

--1.00K

Capital expenditures

-100.00%0.00

23.60%110.00K

536200.00%5.36M

--127.00K

120260.00%6.02M

423.53%89.00K

-50.00%1.00K

-100.00%0.00

-98.87%5.00K

-92.38%17.00K

-99.62%2.00K

-27.31%157.00K

691.07%443.00K

-37.54%223.00K

6.87%529.00K

--216.00K

--56.00K

614.00%357.00K

49400.00%495.00K

--50.00K

--1.00K

Net cash flow from disposal of fixed assets

-100.00%0.00

1733.33%110.00K

--396.00K

--127.00K

--1.02M

-25.00%6.00K

--0.00

100.00%0.00

-100.00%0.00

-94.37%8.00K

-100.00%0.00

-125.00%-29.00K

400.00%280.00K

173.08%142.00K

359.32%459.00K

--116.00K

--56.00K

4.00%52.00K

-17800.00%-177.00K

--50.00K

--1.00K

Net cash flow from intangible asset transactions

-100.00%0.00

496600.00%4.97M

--0.00

99900.00%5.00M

822.22%83.00K

-50.00%1.00K

-100.00%0.00

-96.93%5.00K

-88.89%9.00K

-97.14%2.00K

57.00%157.00K

--163.00K

-73.44%81.00K

-85.86%70.00K

--100.00K

----

--305.00K

--495.00K

----

--0.00

Net cash flow from business transactions

--0.00

1191.36%4.64M

---2.25M

----

--359.00K

----

100.00%0.00

--0.00

-462.32%-1.00M

--0.00

--276.00K

--0.00

Net cash flow from investment products

-333.41%-21.65M

-813.35%-44.87M

-274.18%-49.94M

-48.42%9.91M

-140.04%-5.00M

-75.01%6.29M

163.72%28.67M

187.83%19.21M

-35.89%12.48M

-68.64%25.17M

-167.58%-44.99M

-21.55%-21.88M

109.19%19.46M

8027400.00%80.28M

31211.68%66.58M

---18.00M

---211.68M

100.13%1.00K

95.99%-214.00K

---756.00K

---5.34M

Net cash flow from other investing activities

--0.00

-161.10%-10.00M

100.00%0.00

-156.87%-3.83M

---2.91M

66.63%-1.00M

---25.98M

---1.49M

--0.00

0.00%-3.00M

-100.00%0.00

100.00%0.00

--0.00

---3.00M

123.88%298.00K

-132.35%-79.00K

---1.25M

---34.00K

Cash from non-current investing activities

Net cash flow from investing activities

-96.60%-21.65M

-715.00%-40.34M

-371.95%-67.55M

-39.98%9.78M

-196.02%-11.01M

897.08%6.56M

153.44%24.84M

174.08%16.30M

-28.39%11.47M

-101.03%-823.00K

-170.38%-46.48M

-20.81%-22.00M

107.46%16.02M

264.60%80.05M

10857.33%66.05M

---18.21M

---214.74M

-1157.97%-48.63M

88.58%-614.00K

---3.87M

---5.38M

Financing cash flow

Cash flow from continuous financing activities

-98.62%821.00K

92351.30%142.38M

1120.76%59.74M

2279.45%7.76M

--59.60M

101.82%154.00K

--4.89M

426.00%326.00K

-100.00%0.00

-817.68%-8.46M

-100.00%0.00

-105.57%-100.00K

56.06%206.00K

-153.51%-922.00K

410.21%19.78M

--1.79M

--132.00K

-97.90%1.72M

-78.53%3.88M

--81.98M

--18.06M

Net cash flow from debt Issuance/repayment

----

--0.00

----

-100.00%0.00

--5.00M

----

1900.00%20.00K

-100.00%0.00

----

-99.87%1.00K

205.93%18.56M

--1.08M

--0.00

-44.93%788.00K

-66.41%6.07M

--1.43M

--18.06M

Net cash flow from common stock issuance/repurchase

-100.00%0.00

--139.97M

--47.71M

--18.39M

--59.77M

----

--0.00

-100.00%0.00

--0.00

--82.44M

--0.00

Proceeds from stock option exercised by employees

106.80%821.00K

2050.00%3.31M

9889.09%5.49M

278.83%1.24M

--397.00K

15500.00%154.00K

--55.00K

--326.00K

-100.00%0.00

-100.81%-1.00K

-100.00%0.00

56.06%206.00K

-86.84%123.00K

--1.92M

--117.00K

--132.00K

679.17%935.00K

--0.00

--120.00K

----

Proceeds from issuance of warrants

----

---905.00K

--4.22M

--11.55M

----

Net cash flow from other financing activities

100.00%0.00

--0.00

1537.89%2.31M

---23.41M

---564.00K

100.00%0.00

---161.00K

100.00%0.00

----

-710.71%-8.48M

----

---100.00K

----

---1.05M

68.07%-699.00K

----

--0.00

100.00%0.00

---2.19M

---2.01M

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-98.62%821.00K

92351.30%142.38M

1120.76%59.74M

2279.45%7.76M

--59.60M

101.82%154.00K

--4.89M

426.00%326.00K

-100.00%0.00

-817.68%-8.46M

-100.00%0.00

-105.57%-100.00K

56.06%206.00K

-153.51%-922.00K

410.21%19.78M

--1.79M

--132.00K

-97.90%1.72M

-78.53%3.88M

--81.98M

--18.06M

Net cash flow

Beginning cash balance

210.13%85.30M

-32.38%30.40M

80.41%61.94M

72.10%58.29M

-38.92%27.50M

-41.22%44.96M

-75.67%34.33M

-81.78%33.87M

-76.37%45.03M

-46.34%76.49M

67.70%141.09M

49.94%185.88M

-47.38%190.61M

-66.88%142.54M

-81.45%84.13M

--123.97M

--362.27M

1794.80%430.31M

2978.95%453.62M

--22.71M

--14.73M

Current period cash flow changes

-237.09%-42.20M

414.46%54.90M

-396.69%-31.54M

685.59%3.65M

375.68%30.78M

44.50%-17.46M

116.46%10.63M

101.04%465.00K

-136.17%-11.17M

-165.43%-31.46M

-210.60%-64.60M

-12.43%-44.80M

98.02%-4.73M

170.65%48.07M

350.52%58.41M

---39.84M

---238.29M

-191.29%-68.04M

-392.27%-23.31M

--74.54M

--7.98M

Effect of exchange rate changes

-962.50%-276.00K

181.30%346.00K

-297.47%-468.00K

212.12%206.00K

150.00%32.00K

158.02%123.00K

-25.47%237.00K

186.84%66.00K

-140.25%-64.00K

61.52%-212.00K

-48.79%318.00K

94.91%-76.00K

-46.82%159.00K

11.56%-551.00K

-59.49%621.00K

---1.49M

--299.00K

-123.63%-623.00K

108.01%1.53M

--2.64M

--737.00K

Ending cash balance

-26.05%43.10M

210.13%85.30M

-32.38%30.40M

80.41%61.94M

72.11%58.29M

-38.92%27.50M

-41.22%44.96M

-75.67%34.33M

-81.78%33.87M

-76.37%45.03M

-46.34%76.49M

67.70%141.09M

49.94%185.88M

-47.38%190.61M

-66.88%142.54M

--84.13M

--123.97M

272.53%362.27M

1794.80%430.31M

--97.25M

--22.71M

Free cash flow

11.61%-21.09M

-95.16%-47.59M

-47.99%-28.62M

12.37%-14.22M

-5.67%-23.86M

-10.95%-24.38M

-4.93%-19.34M

28.73%-16.23M

-4.75%-22.58M

28.48%-21.98M

35.49%-18.43M

-2.82%-22.77M

10.35%-21.55M

-47.26%-30.73M

0.11%-28.57M

---22.15M

---24.04M

-233.11%-20.87M

-425.25%-28.61M

---6.26M

---5.45M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did ATAI Life Sciences NV Generate?



ATAI Life Sciences NV generated -102.67M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did ATAI Life Sciences NV's Operating Cash Flow Change Year Over Year?



ATAI Life Sciences NV's operating cash flow increased by -24.55% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does ATAI Life Sciences NV Spend on Capital Expenditures?



ATAI Life Sciences NV spent 10.87M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has ATAI Life Sciences NV's Financing Cash Flow Changed?



ATAI Life Sciences NV used 269.48M in financing activities in the latest quarter.

What is free cash flow and why does it matter for ATAI?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was ATAI Life Sciences NV’s free cash flow in the latest quarter?



Free cash flow was -113.54M reflecting a -37.57% change from the previous year.